{"title": "What's in New Anthrax Vaccine? Aluminum, Formaldehyde and Benzethonium Chloride", "author": "Lisa P", "url": "https://childrenshealthdefense.org/defender/new-anthrax-vaccine-toxic-side-effects/", "hostname": "childrenshealthdefense.org", "description": "\"You can't make this stuff up,\" wrote Meryl Nass, M.D., commenting on the lack of efficacy, toxic ingredients and major side effects associated with Emergent BioSolutions' new anthrax vaccine that won FDA approval last week.", "sitename": "Children's Health Defense", "date": "2023-07-24", "cleaned_text": "Miss a day, miss a lot. [Subscribe to The Defender's Top News of the Day](https://childrenshealthdefense.org/about-us/sign-up/?utm_source=top_of_article&utm_medium=the_defender&utm_campaign=sign_ups). It's free. Emergent BioSolutions' new anthrax vaccine side effects, according [package Food Administration (FDA), [approved the vaccine last week](https://childrenshealthdefense.org/defender/fda-approves-cyfendus-anthrax-vaccine-adults/), posted the package insert late Friday. \"Is a [Meryl Nass, M.D.](https://childrenshealthdefense.org/authors/meryl-nass-md/), a bioterrorism and anthrax analysis of the insert on [Substack](https://merylnass.substack.com/p/the-new-anthrax-vaccine-cyfendus). \"You can't make Cyfendus used to induce animals. published in [Neuromolecular Medicine](https://pubmed.ncbi.nlm.nih.gov/17114826/) linked the aluminum adjuvant the existing anthrax suffered with but so did many troops who were never deployed but who had also been vaccinated against anthrax \u2014 which led researchers to [study the vaccine](https://pubmed.ncbi.nlm.nih.gov/10198799/) as a likely cause of the illness. According to detergents, is [highly toxic if ingested](https://cameochemicals.noaa.gov/chemical/19856). Too few cases worldwide to test for efficacy The new [Cyfendus](https://www.fda.gov/vaccines-blood-biologics/vaccines/cyfendus) vaccine is an updated version of Emergent's [BioThrax](https://www.fda.gov/vaccines-blood-biologics/vaccines/biothrax), also known as [Anthrax Vaccine which the company has been producing since 2002. Emergent said prior to last week's approval, it had been delivering Cyfendus to the U.S. Department of Health and Human Services (HHS) since 2019, under [ pre-emergency use authorization status](https://www.ncbi.nlm.nih.gov/books/NBK53122/). Cyfendus approved only for confirmed exposure to Bacillus anthracis, also known as anthrax, but it must be administered together with other antibacterial drugs. The drug is administered by intramuscular injection as series of two doses, two weeks apart. BioThrax required three doses over four weeks. Nass told Defender](https://childrenshealthdefense.org/defender/) that if someone then get then patiently wait a month to that with antibiotics is a tacit admission that the vaccine \"doesn't work.\" Nass told The Defender there are too few anthrax cases worldwide to study its efficacy in people. She cautioned that animal models have limits in predicting human immune responses, so the vaccine's effectiveness remains uncertain. the insert reports that in [logistic regression analysis](https://careerfoundry.com/en/blog/data-analytics/what-is-logistic-regression/) of testing done rabbits, the treatment demonstrated a \"70% probability of survival\" eight weeks after the dose was administered. That the twin pregnancy), 1 in miscarriage and there were 2 infants (18.2 born with major birth defects.\" The vaccine also caused other major side effects. 65% of subjects had limited use of their arm after the shot. 84% of subjects had a systemic reaction, second none of the six reported deaths or serious adverse events that happened in the clinical trial \"were determined to be related to the administration Cyfendus.\" In the approval letter, the FDA told Emergent it did not refer the application review Health Defense, told The Defender he found approval of the drug very concerning. He said: \"The anthrax vaccine used in the military has been a horrible failure with links to GWI and other neurological sequelae. It will be interesting to see where this goes with ACIP [Advisory Committee on Immunization Practices]. My broadly military a private for-profit government contractor to distribute and produce the anthrax vaccine for the U.S. military, taking over the assets of existing stockpile of anthrax vaccine and the vaccine production plant when the U.S. Department of Defense (DOD) made the vaccine compulsory as part of the [ Anthrax Vaccine Immunization Program](https://www.cdc.gov/anthrax/resources/anthrax-vaccine-research.html) (AVIP) for all 2.5 million military service members \u2014 including active duty and reserve personnel and civilian contractors. The DOD has been administering the vaccine to service members since the 1970s. After the [ 2001 anthrax scare](https://www.history.com/news/anthrax-attacks-terrorism-letters), the company restarted production of the anthrax vaccine. The company works with HHS, the Defense Advanced Research Projects Agency, the Biomedical Advanced Research and Development Authority (BARDA), and the National Institute of Allergy and Infectious Diseases, for its anthrax vaccine are the Centers for Disease Control and Prevention, which buys it for the [Strategic National Stockpile](https://aspr.hhs.gov/SNS/Pages/default.aspx), and BARDA. Those contracts alone have yielded at least $1 billion for the Its [COVID-19](https://childrenshealthdefense.org/defender_category/covid/) vaccine for Johnson & Johnson and AstraZeneca, but its plant was shut down in 2021 when it was revealed the [ company hid likely contamination](https://www.nytimes.com/2022/05/10/us/politics/emergent-fda-vaccine-covid-contaminated.html) problems at the plant from FDA inspectors. It eventually had to destroy 400 million vaccine doses \u2014 which led its share price to fall from $133 to $7. The company has been traded publicly since 2006. Emergent's stock price, which crashed to $7 per share after its COVID-19 vaccine production debacle, rose 30% after it announced FDA approval of Cyfendus last week. "}